Emily Hill

Emily Hill

Director of Finance/CFO chez REPLIMUNE GROUP, INC.

Fortune : 898 659 $ au 31/03/2024

44 ans
Health Technology
Consumer Services
Finance

Profil

Emily Hill is currently the Chief Financial Officer at Replimune Group, Inc. She previously worked as the Director at Greenhill Humane Society SPCA, Senior Manager-Investor Relations at Genzyme Corp., Associate-Biotech Equity Research at Summer Street Capital Partners LLC, Head-Investor Relations Contact at Warner Chilcott Plc, and SVP & Head-Investor Relations at PTC Therapeutics, Inc. Ms. Hill received her undergraduate degree from Hamilton College (New York), her graduate degree from Tufts University School of Medicine, and her MBA from Fordham Gabelli School of Business.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
01/04/2024 109 995 ( 0,18% ) 898 659 $ 31/03/2024
13/04/2023 0 ( -.--% ) - $ 31/03/2024

Postes actifs de Emily Hill

SociétésPosteDébut
REPLIMUNE GROUP, INC. Director of Finance/CFO 19/09/2023
Tous les postes actifs de Emily Hill

Anciens postes connus de Emily Hill

SociétésPosteFin
Investor Relations Contact -
Investor Relations Contact 01/01/2010
Corporate Officer/Principal -
PTC THERAPEUTICS, INC. Director of Finance/CFO -
Director/Board Member -
Voir l'expérience en détail de Emily Hill

Formation de Emily Hill

Hamilton College (New York) Undergraduate Degree
Tufts University School of Medicine Graduate Degree
Fordham Gabelli School of Business Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Emily Hill

Relations

100 +

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
PTC THERAPEUTICS, INC.

Health Technology

REPLIMUNE GROUP, INC.

Health Technology

Entreprise privées4

Health Technology

Finance

Commercial Services

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Emily Hill